Literature DB >> 19760627

Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.

Maciej Salagierski1, Gerald W Verhaegh, Sander A Jannink, Frank P Smit, Daphne Hessels, Jack A Schalken.   

Abstract

BACKGROUND: PCA3 is one of the most prostate cancer (PrCa)-specific markers described so far. Recently, a new genomic structure of PCA3 as well as new flanking and overlapping gene transcripts has been identified. Furthermore, a co-regulation of PCA3 and its overlapping gene PRUNE2(BMCC1) has been suggested. Our aim was to assess the diagnostic performance of a new PCA3 isoform (PCA3-TS4) and to study the interactions between PCA3 and BMCC1 in PrCa.
METHODS: We used SYBR Green quantitative (q)PCR with specific primers to compare PCA3 and BMCC1 expression of normal versus tumor tissue of human prostate. PCA3-TS4 plasmid was created to calculate the absolute amounts of PCA3 transcripts. The androgen regulation of PCA3 and BMCC1 expression was studied in LNCaP and 22Rv1 cells stimulated with 5alpha-dihydrotestosterone.
RESULTS: We have not found any relevant diagnostic advantage of the PCA3-TS4 isoform over the "classical" PCA3 isoform in our group of PrCa patients. Additionally, PCA3-TS4 appears to be only a minor PCA3 transcript. We were also unable to confirm the hypothesis that BMCC1 isoforms are androgen-induced in vitro.
CONCLUSIONS: Despite the presence of the recently identified marginal PCA3 transcripts in human PrCa, the previously described major PCA3 isoform still constitutes the best target for diagnostic purposes. PCA3 and BMCC1 are overlapping genes in reverse orientation that do not appear to be co-regulated. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19760627     DOI: 10.1002/pros.21040

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

Review 1.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

2.  Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy.

Authors:  R Binato; T de Souza Fernandez; C Lazzarotto-Silva; B Du Rocher; A Mencalha; L Pizzatti; L F Bouzas; E Abdelhay
Journal:  Cell Prolif       Date:  2012-11-16       Impact factor: 6.831

Review 3.  Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score.

Authors:  Yue Wang; Xiao-Jun Liu; Xu-Dong Yao
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

4.  PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.

Authors:  Ahmad Salameh; Alessandro K Lee; Marina Cardó-Vila; Diana N Nunes; Eleni Efstathiou; Fernanda I Staquicini; Andrey S Dobroff; Serena Marchiò; Nora M Navone; Hitomi Hosoya; Richard C Lauer; Sijin Wen; Carolina C Salmeron; Anh Hoang; Irene Newsham; Leandro A Lima; Dirce M Carraro; Salvatore Oliviero; Mikhail G Kolonin; Richard L Sidman; Kim-Anh Do; Patricia Troncoso; Christopher J Logothetis; Ricardo R Brentani; George A Calin; Webster K Cavenee; Emmanuel Dias-Neto; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 5.  Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma.

Authors:  Pierre Combe; Eleonore de Guillebon; Constance Thibault; Clémence Granier; Eric Tartour; Stéphane Oudard
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

6.  A new age for vaccine therapy in renal cell carcinoma.

Authors:  Sumanta K Pal; Adriana Hu; Robert A Figlin
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

Review 7.  Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.

Authors:  Stefano Salciccia; Anna Laura Capriotti; Aldo Laganà; Stefano Fais; Mariantonia Logozzi; Ettore De Berardinis; Gian Maria Busetto; Giovanni Battista Di Pierro; Gian Piero Ricciuti; Francesco Del Giudice; Alessandro Sciarra; Peter R Carroll; Matthew R Cooperberg; Beatrice Sciarra; Martina Maggi
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

8.  Identification of single- and multiple-class specific signature genes from gene expression profiles by group marker index.

Authors:  Yu-Shuen Tsai; Kripamoy Aguan; Nikhil R Pal; I-Fang Chung
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

9.  In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis.

Authors:  Elaine Marshall; Jacqueline Lowrey; Sheila MacPherson; Jacqueline A Maybin; Frances Collins; Hilary O D Critchley; Philippa T K Saunders
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

10.  BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells.

Authors:  Janelle L Harris; Renée S Richards; Clement W K Chow; Soon Lee; Misook Kim; Marion Buck; Linda Teng; Raymond Clarke; Robert A Gardiner; Martin F Lavin
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.